Q4 2022 Holdings
Filed 2023-02-14 | 90 holdings | $3.0B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Guardant Health Inc | NOTE 11/1 | 40131MAB5 | $156.7M | $250,022,000 | 5.3% |
| Nanostring Technologies Inc | NOTE 2.625% 3/0 | 63009RAD1 | $118.2M | $145,520,000 | 4.0% |
| Novocure LTD | NOTE 11/0 | 67011XAB9 | $117.6M | $131,834,000 | 3.9% |
| Exact Sciences Corp | NOTE 0.375% 3/0 | 30063PAC9 | $109.6M | $139,000,000 | 3.7% |
| Alphatec Hldgs Inc | NOTE 0.750% 8/0 | 02081GAB8 | $103.1M | $112,250,000 | 3.5% |
| Nevro Corp | NOTE 2.750% 4/0 | 64157FAC7 | $100.2M | $109,251,000 | 3.4% |
| Glaukos Corp(GKOS) | COM | 377322102 | $72.6M | 1,661,851 | 2.4% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $71.5M | 3,341,300 | 2.4% |
| Biogen Inc(BIIB) | COM | 09062X103 | $69.9M | 252,542 | 2.3% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $65.3M | 1,362,278 | 2.2% |
| Natera Inc(NTRA) | COM | 632307104 | $65.1M | 1,621,012 | 2.2% |
| Bridgebio Pharma Inc | NOTE 2.500% 3/1 | 10806XAB8 | $63.7M | $141,500,000 | 2.1% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $63.5M | 3,469,674 | 2.1% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $61.0M | 1,548,110 | 2.0% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $59.2M | 223,120 | 2.0% |
| Deciphera Pharmaceuticals in(DCPHEUR) | COM | 24344T101 | $53.6M | 3,271,513 | 1.8% |
| Karyopharm Therapeutics Inc | NOTE 3.000%10/1 | 48576UAA4 | $49.4M | $65,976,000 | 1.7% |
| Ionis Pharmaceuticals Inc | NOTE 4/0 | 462222AD2 | $48.9M | $52,740,000 | 1.6% |
| Nevro Corp(NVROEUR) | COM | 64157F103 | $47.2M | 1,192,298 | 1.6% |
| Travere Therapeutics Inc | NOTE 2.500% 9/1 | 761299AB2 | $46.6M | $50,536,000 | 1.6% |
| Irhythm Technologies Inc(IRTC) | COM | 450056106 | $46.6M | 497,667 | 1.6% |
| Align Technology Inc(ALGN) | COM | 016255101 | $46.4M | 219,930 | 1.6% |
| Outset MED Inc(OMGBP) | COM | 690145107 | $44.0M | 1,704,552 | 1.5% |
| Amyris Inc | NOTE 1.500%11/1 | 03236MAJ0 | $43.3M | $137,850,000 | 1.4% |
| Orthopediatrics Corp(KIDS) | COM | 68752L100 | $41.5M | 1,044,699 | 1.4% |
| Exact Sciences Corp | NOTE 0.375% 3/1 | 30063PAB1 | $40.1M | $48,300,000 | 1.3% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $37.7M | 2,393,985 | 1.3% |
| Insmed Inc | NOTE 1.750% 1/1 | 457669AA7 | $37.7M | $399,630,000 | 1.3% |
| Neogenomics Inc | NOTE 1.250% 5/0 | 64049MAA8 | $36.5M | $43,000,000 | 1.2% |
| Penumbra Inc(PEN) | COM | 70975L107 | $36.2M | 162,828 | 1.2% |
| Amgen Inc(AMGN) | COM | 031162100 | $34.4M | 131,100 | 1.2% |
| Bellus Health Inc New(BLU) | COM NEW | 07987C204 | $33.8M | 4,112,494 | 1.1% |
| Ionis Pharmaceuticals Inc | NOTE 0.125%12/1 | 462222AB6 | $33.4M | $36,533,000 | 1.1% |
| Legend Biotech Corp(LEGN) | SPONSORED ADS | 52490G102 | $32.9M | 658,101 | 1.1% |
| Nuvasive Inc | NOTE 0.375% 3/1 | 670704AJ4 | $32.2M | $36,665,000 | 1.1% |
| Neogenomics Inc | NOTE 0.250% 1/1 | 64049MAB6 | $31.9M | $48,678,000 | 1.1% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $31.6M | 1,242,802 | 1.1% |
| Merus N V | COM | N5749R100 | $30.9M | 1,998,084 | 1.0% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $30.6M | 1,455,585 | 1.0% |
| Travere Therapeutics Inc | NOTE 2.250% 3/0 | 89422GAA5 | $28.7M | $31,350,000 | 1.0% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $28.4M | 358,056 | 1.0% |
| Hillevax Inc | COM | 43157M102 | $27.1M | 1,620,216 | 0.9% |
| DAY One Biopharmaceuticals I(DAWN) | COM | 23954D109 | $26.8M | 1,246,539 | 0.9% |
| Dice Therapeutics Inc | COM | 23345J104 | $26.2M | 839,075 | 0.9% |
| Quidelortho Corp(QDEL) | COM | 219798105 | $25.7M | 300,437 | 0.9% |
| Globus MED Inc(GMED) | CL A | 379577208 | $25.5M | 343,626 | 0.9% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $23.8M | 1,493,121 | 0.8% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $22.5M | 726,122 | 0.8% |
| Silk RD MED Inc | COM | 82710M100 | $22.0M | 416,817 | 0.7% |
| Esperion Therapeutics Inc NE(ESPR) | COM | 29664W105 | $21.1M | 3,393,405 | 0.7% |